Clinical trial
Double Blind Placebo Controlled Multicenter Trial for Prevention of IMT Progression in the Ischemic Stroke Patients With High Risk of Cerebral Hemorrhage With Cilostazol and Probucol
NCT02483169 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double Blind Placebo Controlled Multicenter Trial for Prevention of IMT Progression in the Ischemic Stroke Patients With High Risk of Cerebral Hemorrhage With Cilostazol and Probucol
- Lead sponsor
- Asan Medical Center
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- June 30, 2009
- Completion date
- December 31, 2016
- Enrollment
- 800 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.